Bioactivation of Halogenated Hydrocarbons by Cytochrome P4502E1

References

• Kadlubar F. F., Hammons G. J. The role of cytochrome P‐450 in the metabolism of chemical carcinogens. Mammalian Cytochromes P‐450, F. P. Guengerich. CRC Press, Boca Raton, FL 1987; Vol. II: 109
   Google Scholar
• Nelson S. D., Harvison P. J. Roles of cytochromes P‐450 in chemically induced cytotoxicity. Mammalian Cytochromes P‐450, F. P. Guengerich. CRC Press, Boca Raton, FL 1987; Vol. II: 20
   Google Scholar
• Koop D. R. Oxidative and reductive metabolism by cytochrome P4502E1. FASEB J. 1992; 6: 724
   PubMed Web of Science ®Google Scholar
• Koop D. R., Tiemey D. J. Multiple mechanisms in the regulation of ethanol‐inducible cytochrome P450IIE1. Bioessays 1990; 12: 429
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 1989; 40: 243
   Web of Science ®Google Scholar
• Wrighton S. A., Stevens J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 1992; 22: 1
   PubMed Web of Science ®Google Scholar
• Lieber C. S. Hepatic, metabolic and toxic effects of ethanol. Update: Alcoholism: Clin. Exp. Res. 1991; 15: 573
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Kim D. ‐H., Iwasaki M. Role of human cytochrome P‐450 IIEI in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 1991; 4: 168
   PubMed Web of Science ®Google Scholar
• Zimmerman H. J. Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. Appleton‐Century‐Crofts, New York 1978
   Google Scholar
• Plaa G. L., Larson R. E. Relative nephrotoxic properties of chlorinated methane, ethane, and ethylene derivatives in mice. Toxicol. Appl. Pharmacol. 1965; 7: 37
   PubMed Web of Science ®Google Scholar
• Rush G. F., Smith J. H., Newton J. F., Hook J. B. Chemically induced nephrotoxicity: role of metabolic activation. Crit. Rev. Toxicol. 1984; 13: 99
   PubMed Web of Science ®Google Scholar
• Davidson I. W. F., Summer D. D., Parker J. C. Chloroform: a review of its metabolism, teratogenic, mutagenic, and carcinogenic potential. Drug Chem. Toxicol. 1982; 5: 1
   PubMed Web of Science ®Google Scholar
• Brady J. F., Li D., Ishizaki H., Lee M., Ning S. M., Xiao F., Yang C. S. Induction of cytochromes P450IIE1 and P450IIB1 by secondary ketones and the role of P450IIE1 in chloroform metabolism. Toxicol. Appl. Pharmacol. 1989; 100: 342
   PubMed Web of Science ®Google Scholar
• Smith J. H., Maita K., Sleight S. D., Hook J. B. Mechanism of chloroform toxicity. I. Time course of chloroform toxicity in male and female mice. Toxicol. Appl. Pharmacol. 1983; 70: 467
   PubMed Web of Science ®Google Scholar
• Hong J. Y., Pan J., Ning S. M., Yang C. S. Molecular basis for the sex‐related difference in renal N‐nitrosodimethylamine demethylase in C3H/ He J mice. Cancer Res. 1989; 49: 2973
   PubMed Web of Science ®Google Scholar
• Pohl L. R., George J. W., Satoh H. Strain and sex differences in chloroform‐induced nephrotoxicity. Drug Metab. Dispos. 1984; 12: 304
   PubMed Web of Science ®Google Scholar
• Recknagel R. O. A new direction in the study of carbon tetrachloride metabolism. Life Sci. 1983; 33: 401
   PubMed Web of Science ®Google Scholar
• Recknagel R. O., Glende E. A. Carbon tetrachloride toxicity: an example of lethal cleavage. Crit. Rev. Toxicol. 1973; 2: 263
   Google Scholar
• Rechnagel R. O., Glende E. A., Hruszkewyca A. M. New data supporting an obligatory role for lipid peroxidation in carbon tetrachloride‐induced loss of aminopyrine demethylase, cytochrome P‐450 and glucose‐6‐phosphatase. Biological Reactive Intermediates: Formation, Toxicity and Inactivation, D. J. Jollow, J. J. Docsis, R. Snyder, H. Vainio. Plenum Press, New York 1977; 417
   Google Scholar
• Slater T. F. Free radicals as reactive intermediates in tissue injury. Biological Reactive Intermediates‐II: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, C. M. Witmer. Plenum Press, New York 1982; 575
   Google Scholar
• Uehleke H. Binding of haloalkanes to liver microsomes. Biological Reactive Intermediates: Formation, Toxicity and Inactivation, D. J. Jollow, J. J. Kocsis, R. Snyder, H. Vainio. Plenum Press, New York 1977; 431
   Google Scholar
• Sipes I. G., Gandolfi A. J. Role of reactive intermediates in halothane associated liver injury. Biological Reactive Intermediates‐II: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, C. M. Witmer. Plenum Press, New York 1982; 603
   Google Scholar
• Wolf C. R., Harrelson W. G., Nastainczyk W. M., Philpot R. M., Kalyanaraman B., Mason R. P. Metabolism of CC14 in hepatic microsomes and reconstituted monooxygenase systems and its relationship to lipid peroxidation. Mol. Pharmacol. 1980; 18: 553
   PubMedGoogle Scholar
• Johansson I., Ingelman‐Sundberg M. Carbon tetrachloride‐induced lipid peroxidation dependent on an ethanol‐inducible form of rabbit liver microsomal cytochrome P450. FEBS Lett. 1985; 183: 265
   PubMed Web of Science ®Google Scholar
• Sipes I. G., Stripp B., Krishna G., Malin H. M., Gillette J. R. Enhanced hepatic microsomal activity by pretreatment of rats with acetone or isopropanol (36996). Proc. Soc. Exp. Biol. Med. 1973; 142: 237
   PubMed Web of Science ®Google Scholar
• Johansson I., Ekstrom G., Sholte B., Puzycki D., Jornvall H., Ingelman‐Sundberg M. Ethanol‐, fasting‐, and acetone‐inducible cytochromes P450 in rat liver: regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry 1988; 27: 1925
   PubMed Web of Science ®Google Scholar
• Lindros K. O., Cai Y., Penttila K. E. Role of ethanol‐inducible cytochrome P‐450IIE1 in carbon tetrachloride‐induced damage to centrilobular hepa‐tocytes from ethanol‐treated rats. Hepatology 1990; 12: 1092
   PubMed Web of Science ®Google Scholar
• Persson J. ‐O., Terelius Y., Ingelman‐Sundberg M. Cytochrome P‐450 dependent formation of reactive oxygen radicals: isozyme‐specific inhibition of P‐450 mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 1990; 20: 887
   PubMed Web of Science ®Google Scholar
• Brady J. F., Xiao F., Wang M. ‐H., Li Y., Ning S. M., Gapac J. M., Yang C. S. Effects of disulfiram on hepatic P450IIE1, other microsomal enzymes, and hepatotoxicity in rats. Toxicol. Appl. Pharmacol. 1991; 108: 366
   PubMed Web of Science ®Google Scholar
• Ekstrom G., von Bahr C., Ingelman‐Sundberg M. Human liver microsomal cytochrome P‐450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction, and NADPH oxidase activity. Biochem. Pharmacol. 1989; 38: 689
   PubMed Web of Science ®Google Scholar
• Sohn D. H., Yun Y. ‐P., Park K. S., Veech R. L., Song B. ‐J. Post‐translational reduction of cytochrome P450IIE by CC14, its substrate. Biochem. Biophys. Res. Commun. 1991; 179: 449
   PubMed Web of Science ®Google Scholar
• English J. C., Anders M. W. Evidence for the metabolism of N‐nitrosodimethylamine and carbon tetrachloride by a common isozyme of cytochrome P‐450. DrugMetab. Dispos. 1985; 13: 449
   PubMedGoogle Scholar
• Storer R. D., Conolly R. B. Comparativein vivo genotoxicity and acute hepatotoxicity of three 1,3‐dihaloethanes. Carcinogenesis 1983; 4: 1491
   PubMedGoogle Scholar
• Hill D. L., Shih T. ‐W., Johnston T. P., Struch R. F. Macromolecular binding and metabolism of the carcinogen 1,2‐dibromoethane. Cancer Res. 1982; 38: 2438
   Google Scholar
• Letz G. A., Pond S. M., Osterloh J. D., Wade R. L., Becker C. E. Two fatalities after acute occupation exposure to ethylene dibromide. JAMA 1984; 252: 2428
   PubMedGoogle Scholar
• Halpert J., Neal R. A. Cytochrome P‐450‐dependent metabolism of 1,1,2,2‐tetrachloroethane to dichloroacetic acidin vitro. Biochem. Pharmacol. 1981; 30: 1366
   PubMed Web of Science ®Google Scholar
• Halpert J. Cytochrome P‐450‐dependent covalent binding of 1,1,2,2‐tetrachloroethanein vitro. Drug Metab. Dispos. 1982; 10: 465
   PubMed Web of Science ®Google Scholar
• Olson M. J., Kim S. G., Reidy C. A., Johnson J. T., Novak R. F. Oxidation of 1,1,1,2‐tetrafluoroethane in rat liver microsomes is catalyzed primarily by cytochrome P450IIE1. Drug Metab. Dispos. 1991; 19: 298
   PubMed Web of Science ®Google Scholar
• Henschler D., Hoos R. Metabolic activation and deactivation mechanisms of di‐, tri‐, and tetrachloroethylenes. Biological Reactive Intermediates‐II: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, C. M. Witmer. Plenum Press, New York 1982; 659
   Google Scholar
• Guengerich F. P., Crawford W. M., Watanabe P. G. Activation of vinyl chloride to covalently bound metabolities: roles of 2‐chloroethyl‐ene oxide and 2‐chloroacetaldehyde. Biochemistry 1979; 18: 5177
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Crawford W. M., Watanabe P. G. Activation of vinyl chloride to covalently bound metabolites: roles of 2‐chloroethy‐lene oxide and 2‐chloroacetaldehyde. Biochemistry 1979; 18: 5177
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Mason P. S., Stott W. T., Fox T. R., Watanabe P. G. Roles of 2‐haloethy‐lene oxides and 2‐haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA. Cancer Res. 1981; 41: 4391
   PubMed Web of Science ®Google Scholar
• Bruckner J. V., Davis B. D., Blancato J. N. Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol. 1989; 20: 31
   PubMed Web of Science ®Google Scholar
• Bolt H. M., Filser J. G., Laib R. J. Covalent binding of haloethylenes. Biological Reactive Intermediates‐II: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, C. M. Witmer. Plenum Press, New York 1982; 667
   Google Scholar
• Henschler D. Halogenated alkenes and alkynes, chap. 11. Bioactivation of Foreign Compounds, M. W. Anders. Academic Press, Orlando, FL 1985
   Google Scholar
• Nakajima T., Okino T., Okuyama S., Kaneko T., Yonekura I., Sato A. Ethanol‐induced enhancement of trichloroethylene metabolism and hepatoxicity: difference from the effect of phenobarbital. Toxicol. Appl. Pharmacol. 1988; 94: 227
   PubMed Web of Science ®Google Scholar
• Okino T., Nakajima T., Nakano M. Morphological and biochemical analyses of trichloroethylene hepatotoxicity: differences in ethanol‐and phenobarbital‐pretreated rats. Toxicol. Appl. Pharmacol. 1991; 108: 379
   PubMedGoogle Scholar
• Nakajima T., Sato A. Enhanced activity of liver drug‐metabolizing enzymes for aromatic and chlorinated hydrocarbons following food deprivation. Toxicol. Appl. Pharmacol. 1979; 50: 549
   PubMed Web of Science ®Google Scholar
• Nakajima T., Wang R. ‐S., Elovaara E., Park S. S., Gelboin H. V., Vainio H. A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. Biochem. Pharmacol. 1992; 43: 251
   PubMed Web of Science ®Google Scholar
• Nakajima T., Wang R. ‐S., Murayama N., Sato A. Three forms of trichloroethylene‐metabolizing enzymes in rat liver induced by ethanol, phenobarbital, and 3‐methylchoIanthrene. Toxicol. Appl. Pharmacol. 1990; 102: 546
   PubMedGoogle Scholar
• Nakajima T., Wang R. ‐S., Katakura Y., Kishi R., Elovaara E., Park S. S., Gelboin H. V., Vainio H. Sex‐, age‐, and pregnancy‐induced changes in the metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. J. Pharmacol. Exp. Ther. 1992; 261: 869
   PubMed Web of Science ®Google Scholar
• Anders M. W., Pohl L. R. Halogenated al‐kanes, chap. 10. Bioactivation of Foreign Compounds, M. W. Anders. Academic Press, Orlando, FL 1985
   Google Scholar
• Vaughn R. W., Sipes I. G., Brown B. R. Role of biotransformation in the toxicity of inhalation anesthetics. Life Sci. 1978; 23: 2447
   PubMed Web of Science ®Google Scholar
• Gandolfi A. J. Biotransformation of inhalation anesthetics: role in producing toxicity. Inhalation‐sanasthesie‐eine Standortbestimmung, H. Laubenthal, C. Puchstein, C. Sirtl. Wissenschaftliche Verlagsabteilung, Abbot GmbH, WiesbadenGermany 1992; 9
   Google Scholar
• Cousins M. J. Halothane hepatitis: what's new?. Drugs 1980; 19: 1
   PubMedGoogle Scholar
• Pohl L. R., Gillette J. R. A perspective on halothane‐induced hepatotoxicity. Anesth. Analg. 1982; 61: 809
   PubMed Web of Science ®Google Scholar
• Neuberger J., Davis M. Advances in understanding of halothane hepatitis. Trends Pharamcol. Sci. 1983; 4: 19
   Google Scholar
• Wood C. L., Gandolfi A. J., VanDyke R. A. Lipid binding of halothane metabolite. Drug. Metab. Dispos. 1976; 4: 305
   PubMedGoogle Scholar
• Poyer J. L., McCay P. B., Weddle C. C., Downs P. E. In vivo spin‐trapping of radicals formed during halothane metabolism. Biochem. Pharmacol. 1981; 30: 1517
   PubMed Web of Science ®Google Scholar
• Ahr H. J., King L. J., Nastainczyk W., Ullrich V. The mechanism of reductive metabolism of halothane by liver cytochrome P‐450. Biochem. Pharmacol. 1982; 31: 383
   PubMed Web of Science ®Google Scholar
• Trudell J. R., Bosterling B., Trevor A. J. Reductive metabolism of halothane by human and rabbit cytochrome P‐450. Binding of I‐chloro‐2,2,2‐trifluoroethyl radical to phospholipids. Mol. Pharmacol. 1982; 21: 710
   PubMed Web of Science ®Google Scholar
• Manno M., Cazzaro S., Rezzadore M. The mechanism of the suicidal reductive inactivation of microsomal cytochrome P‐450 by halothane. Arch. Toxicol. 1991; 65: 191
   PubMed Web of Science ®Google Scholar
• Gandolfi A. J., White R. D., Sipes I. G., Pohl L. R. Bioactivation and covalent binding of halothanein vitro: studies with ‘3H’‐ and ‘14C’‐hal‐othane. J. Pharmacol. Exp. Ther. 1980; 214: 721
   PubMed Web of Science ®Google Scholar
• Sipes I. G., Gandolfi A. J., Pohl L. R., Krishna G., Brown B. R. Comparison of the biotransformation and hepatotoxicity of halothane and deu‐terated halothane. J. Pharmacol. Exp. Ther. 1980; 214: 716
   PubMed Web of Science ®Google Scholar
• Davis M., Eddleston A. L., Neuberger J., Vergani D., Vergani G. M., Williams R. Halothane hepatitis. N. Engl. J. Med. 1980; 303: 66
   PubMedGoogle Scholar
• Neuberger J., Vergani G. M., Tredger J. M., Davis M., Williams R. Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane‐induced necrosis. Gut 1981; 22: 669
   PubMed Web of Science ®Google Scholar
• Gruenke L. D., Konopka K., Koop D. R., Waskell L. A. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P‐450 using a gas chromatographic mass spectrometric assay. J. Pharmacol. Exp. Ther. 1988; 246: 454
   PubMed Web of Science ®Google Scholar
• VanDyke R. A., Baker M. T., Jansson I., Schenkman J. Reductive metabolism of halothane by purified cytochrome P‐450. Biochem. Pharmacol. 1988; 37: 2357
   PubMedGoogle Scholar
• Bentley J. B., Vaughan R. W., Gandolfi A. J., Cork R. C. Halothane biotransformation in obese and nonobese patients. Anesthesiology 1982; 57: 94
   PubMed Web of Science ®Google Scholar
• Raucy J. L., Lasker J. M., Kroner J. C., Salazar D. E., Lieber C. S., Corcoran G. B. Induction of cytochrome P450IIE1 in the obese overfed rat. Mol. Pharmacol. 1991; 39: 275
   PubMed Web of Science ®Google Scholar
• Hoffman J., Konopka K., Buckhorn C., Koop D. R., Waskell L. Ethanol‐inducible cytochrome P450 in rabbits metabolizes enfiurane. Br. J. Anaesth. 1989; 63: 103
   PubMedGoogle Scholar
• Tsutsumi R., Leo M. A., Kim C., Tsutsumi M., Lasker J. M., Lowe N., Lieber C. S. Interaction of ethanol with enfiurane metabolism and toxicity: role of P450IIE1. Alcoholism: Clin. Exp. Res. 1990; 141: 174
   Google Scholar
• Waskell L., Canova‐Davis E., Philpot R., Parandoush Z., Chiang J. Y. L. Identification of the enzymes catalyzing metabolism of methoxyflurane. Drug. Metab. Dispos. 1986; 14: 643
   PubMedGoogle Scholar
• Miller M. S., Gandolfi A. J., Vaughan R. W., Bentley J. B. Disposition of enfiurane in obese patients. J. Pharmacol. Exp. Ther. 1980; 215: 292
   PubMed Web of Science ®Google Scholar
• Lieber C. S. Biochemical and molecular basis of alcohol‐induced injury to liver and other tissues. N. Engl. J. Med. 1988; 319: 1639
   PubMed Web of Science ®Google Scholar
• Lane B. P., Lieber C. S. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am. J. Pathol. 1966; 49: 593
   PubMed Web of Science ®Google Scholar
• Lieber C. S., DeCarli L. M. Hepatic microsomal ethanol‐oxidizing system:in vitro characteristics and adaptive propertiesin vivo. J. Biol. Chem. 1970; 245: 2505
   PubMed Web of Science ®Google Scholar
• Koop D. R., Morgan E. T., Tarr G. E., Coon M. J. Purification and characterization of a unique isozyme of cytochrome P450 from liver microsomes of ethanol‐treated rabbits. J. Biol. Chem. 1982; 257: 13951
   PubMedGoogle Scholar
• Morgan E. T., Koop D. R., Coon M. J. Catalytic activity of cytochrome P450 isozyme 3a isolated from liver microsomes of ethanol‐treated rabbits. J. Biol. Chem. 1982; 257: 13951
   PubMed Web of Science ®Google Scholar
• Ryan D. E., Ramanathan L., Iida S., Thomas P. E., Haniu M., Shively J. E., Lieber C. S., Levin W. Characterization of a major form of rat hepatic microsomal cytochrome P‐450 induced by isoniazid. J. Biol. Chem. 1985; 260: 6385
   PubMed Web of Science ®Google Scholar
• Ryan D. E., Koop D. R., Thomas P. E., Coon M. J., Levin W. Evidence that isoniazid and ethanol induce the same microsomal cytochrome P‐450 in rat liver, an isozyme homologous to rabbit liver cytochrome P‐450 isozyme 3a. Arch. Biochem. Biophys. 1986; 246: 633
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Coon M. J., Estabrook R. W., Feyereisen R., Fujii‐Kuriyama Y., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Loper J. C., Sato R., Waterman M. R., Waxman D. J. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol. 1991; 10: 1
   PubMed Web of Science ®Google Scholar
• Yang C. S., Tu Y. Y., Koop D. R., Coon M. J. Metabolism of nitrosamines by purified rabbit liver cytochrome P450 isozymes. Cancer Res. 1985; 45: 1140
   PubMed Web of Science ®Google Scholar
• Morgan E. T., Koop D. R., Coon M. J. Comparison of six rabbit liver cytochrome P450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem. Biophys. Res. Commun. 1983; 112: 8
   PubMed Web of Science ®Google Scholar
• Koop D. R., Crump B. L., Nordblom G. D., Coon M. J. Immunochemical evidence for induction of the alcohol‐oxidizing cytochrome P‐450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Proc. Natl. Acad. Sci. USA 1985; 82: 4065
   PubMed Web of Science ®Google Scholar
• Kim S. G., Williams D. E., Schuetz E. G., Guzelian P. S., Novak R. F. Pyridine induction of cytochrome P‐450 in the rat: role of P‐450j (alcohol‐inducible form) in pyridine N‐oxidation. J. Pharmacol. Exp. Ther. 1988; 246: 1175
   PubMed Web of Science ®Google Scholar
• Clark H., Powis G. Effect of acetone administeredin vivo upon hepotic microsomal drug metabolizing activity in the rat. Biochem. Pharmacol. 1974; 23: 1015
   PubMed Web of Science ®Google Scholar
• Morgan E. T., Devine M., Skett P. Changes in the rat hepatic mixed function oxidase system associated with chronic ethanol vapor inhalation. Biochem. Pharmacol. 1981; 30: 595
   PubMedGoogle Scholar
• Koop D. R., Casazza J. P. Identification of ethanol‐inducible P450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J. Biol. Chem. 1985; 260: 13607
   PubMed Web of Science ®Google Scholar
• Raucy J., Fernandes P., Black M., Yang S. L., Koop D. R. Identification of a human liver cytochrome P‐450 exhibiting catalytic and immunochemical similarities to cytochrome P‐4503a of rabbit liver. Biochem. Pharmacol. 1987; 36: 2921
   PubMed Web of Science ®Google Scholar
• Wrighton S. A., Thomas P. E., Molowa D. T., Haniu M., Shively J. E., Maines S. L., Watkins P. B., Parker G., Mendez‐Picon G., Levin W., Guzelian P. S. Characterization of ethanolinducible human liver N‐nitrosodimethylamine demethylase. Biochemistry 1986; 25: 6731
   PubMed Web of Science ®Google Scholar
• Lasker J. M., Raucy J. L., Kubota S., Boswick B. P., Black M., Lieber C. S. Purification and characterization of human liver cytochrome P450Alc. Biochem. Biophys. Res. Commun. 1987; 148: 232
   PubMed Web of Science ®Google Scholar
• Raucy J. L., Lasker J. M., Lieber C. S., Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 1989; 271: 270
   PubMed Web of Science ®Google Scholar
• Peter R., Bocker R., Beaune P. H., Iwasaki M., Guengerich F. P., Yang C. S. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P‐450IIE1. Chem. Res. Toxicol. 1990; 3: 566
   PubMed Web of Science ®Google Scholar
• Tsutsumi M., Lasker J. M., Shimizu M., Rosman A. S., Lieber C. S. The intralobular distribution of ethanol‐inducible P450IIE1 in rat and human liver. Hepatology 1989; 10: 437
   PubMed Web of Science ®Google Scholar
• Song B. ‐J., Gelboin H. V., Park S. ‐S., Yang C. S., Gonzalez F. J. Complementary DNA and protein sequences of ethanol‐inducible rat and human cytochrome P450s. J. Biol. Chem. 1986; 261: 16689
   PubMed Web of Science ®Google Scholar
• Khani S. C., Zaphiropoulos P. G., Fujita V. S., Porter T. D., Koop D. R., Coon M. J. cDNA and derived amino acid sequence of ethanol‐inducible rabbit liver cytochrome P‐450 isozyme 3a(P‐450ALC). Proc. Natl. Acad. Sci. USA 1987; 84: 638
   PubMed Web of Science ®Google Scholar
• Porter T. D., Khani S. C., Coon M. J. Induction and tissue‐specific expression of rabbit cytochrome P450IIE1 and IIE2 genes. Mol. Pharmacol. 1989; 36: 61
   PubMed Web of Science ®Google Scholar
• Umeno M., McBride O. W., Yang C. S., Gelboin H. V., Gonzalez F. J. Human ethanol‐inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA‐directed expression. Biochemistry 1988; 27: 9006
   PubMed Web of Science ®Google Scholar
• Hong J. ‐Y., Pan J., Dong Z., Ning S., Yang C. Regulation of N‐nitrosodimethylamine demethylase in rat liver and kidney. Cancer Res. 1987; 47: 5948
   PubMed Web of Science ®Google Scholar
• Eliasson E., Johansson I., Ingelman‐Sundberg M. Ligand‐dependent maintenance of ethanol‐inducible cytochrome P450 in primary hepatocyte cell cultures. Biochem. Biophys. Res. Commun. 1988; 150: 436
   PubMed Web of Science ®Google Scholar
• Eliasson E., Johansson I., Ingelman‐Sundberg M. Substrate‐, hormone‐, and cAMP‐regulated cytochrome P450 degradation. Proc. Natl. Acad. Sci. USA 1990; 87: 3225
   PubMed Web of Science ®Google Scholar
• Wu D. F., Clejan L., Potter B., Cederbaum A. I. Rapid decrease of cytochrome P450IIE1 in primary hepatocyte culture and its maintenance by added 4‐methylpyrazole. Hepatology 1990; 12: 1379
   PubMed Web of Science ®Google Scholar
• Sinclair J. F., McCaffrey J., Sinclair P. R., Bement W. J., Lambrecht L. K., Wood S. G., Smith E. L., Schenkman J. B., Guzelian P. S., Park S. S., Gelboin H. V. Ethanol increases cytochromes P450IIE1, IIB1/2, and IIIA in cultured rat hepatocytes. Arch. Biochem. Biophys. 1991; 284: 360
   PubMedGoogle Scholar
• Ronis M. J. J., Johansson I., Hultenby K., Lagercrantz J., Glaumann H., Ingelman‐Sundberg I. Acetone regulated synthesis and degradation of cytochrome P4502E1 and cytochrome P4502B1 in rat liver. Eur. J. Biochem. 1991; 198: 383
   PubMedGoogle Scholar
• Song B. ‐J., Veech R. L., Park S. S., Gelboin H. V., Gonzalez F. J. Induction of rat hepatic N‐nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 1989; 264: 3568
   PubMed Web of Science ®Google Scholar
• Tierney D. J., Haas A. L., Koop D. R. Degradation of cytochrome P4502E1: selective loss after labilization of the enzyme. Arch. Biochem. Biophys. 1992; 293: 9
   PubMed Web of Science ®Google Scholar
• Kraner J. C., Lasker J. M., Corcoran G. B., Ray S. D., Raucy J. L. Induction of P4502E1 by acetone in isolated rabbit hepatocytes: role of increased protein and mRNA synthesis. Biochem. Pharmacol.
   Google Scholar
• Tu Y. Y., Peng R., Chang Z. ‐F., Yang C. S. Induction of a high affinity nitrosamine de‐methylase in rat liver microsomes by acetone and isopropanol. Chem. Biol. Inter. 1983; 44: 247
   PubMed Web of Science ®Google Scholar
• Diehl A. M., Bisgaard H. C., Kren B. T., Steer C. J. Ethanol interferes with regeneration‐associated changes in biotransforming enzymes: a potential mechanism underlying ethanol's carcinogenicity?. Hepatology 1991; 13: 722
   PubMed Web of Science ®Google Scholar
• Ronis M. J. J., Lumpkin C. K., Ingelman‐Sundberg M., Badger T. M. Effects of short‐term ethanol and nutrition on the hepatic microsomal monooxygenase system in a model utilizing total enteral nutrition in the rat. Alcoholism: Clin. Exp. Res. 1991; 15: 693
   PubMedGoogle Scholar
• Badger T. M., Crouch J., Irby D., Hakkak R., Shahare M. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions. J. Pharmacol. Exp. Ther.
   Google Scholar
• Badger T. M., Ronis M. J. J., Lumpkin C. K., Shahare M., Irby D., Huang J., Valentine C. R., Mercado C., Thomas P. E., Ingleman‐Sundberg M., Crouch J. Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat. J. Pharmacol. Exp. Ther.
   Google Scholar
• Ronis J. J. M., Crouch J., Mercado C., Irby D., Huang J., Valentine C. R., Lumpkin C. K., Ingelman‐Sundberg M., Badger T. M. Cytochrome P450 CYP2E1 induction during chronic alcohol exposure occurs by a two‐step mechanism associated with blood alcohol concentrations in rats. J. Pharmacol. Exp. Ther.
   Google Scholar
• Badger T. M., Huang J., Ronis M., Lumpkin C. K. Induction of cytochrome P4502E1 during chronic ethanol exposure occurs via transcription of CYP2E1 gene when blood alcohol concentrations are high. Biochem. Biophys. Res. Commun.
   Google Scholar
• Kubota S., Lasker J. M., Lieber C. S. Molecular regulation of ethanol‐inducible cytochrome P450IIE1 in hamsters. Biochem. Biophys. Res. Commun. 1988; 150: 304
   PubMed Web of Science ®Google Scholar
• Takahashi T., Lasker J. M., Rosman A. S., Lieber C. S. Induction of P4502E1 in human liver by ethanol is due to a corresponding increase in encoding mRNA. Hepatology
   Google Scholar
• Kim S. G., Novak R. F. Induction of rat hepatic P450IIE1 (CYP2El) by pyridine: evidence for a role of protein synthesis in the absence of transcriptional activation. Biochem. Biophys. Res. Commun. 1990; 166: 1072
   PubMed Web of Science ®Google Scholar
• Hong J., Pan J., Gonzalez F. J., Gelboin H. V., Yang C. S. The induction of a specific form of cytochrome P‐450 (P‐450j) by fasting. Biochem. Biophys. Res. Commun. 1987; 142: 1077
   PubMed Web of Science ®Google Scholar
• Johansson I., Lindros K. O., Eriksson H., Ingelman‐Sundberg M. Transcriptional control of CYP2E1 in the perivenous liver region and during starvation. Biochem. Biophys. Res. Commun. 1990; 173: 331
   PubMed Web of Science ®Google Scholar
• Nakajima T., Elovaara E., Park S. S., Gelboin H. V., Vainio H. Immunochemical detection of cytochrome P450 isozymes induced in rat liver by n‐hexane, 2‐hexanone and acetonyl acetone. Arch. Toxicol. 1991; 65: 542
   PubMed Web of Science ®Google Scholar
• Nakajima T., Koyama Y., Sato A. Dietary modification of metabolism and toxicity of chemical substances with special reference to carbohydrate. Biochem. Pharmacol. 1982; 31: 1005
   PubMed Web of Science ®Google Scholar
• Yang C. S., Brady J. F., Hong J. ‐Y. Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity. FASEB J. 1992; 6: 737
   PubMed Web of Science ®Google Scholar
• Yoo J. ‐S. H., Ning S. M., Pantuck C. B., Pantuck E. J., Yang C. S. Regulation of hepatic microsomal cytochrome P450IIEI level by dietary lipids and carbohydrates in rats. J. Nutr. 1991; 121: 959
   PubMed Web of Science ®Google Scholar
• Yun Y. ‐P., Casazza J. P., Sohn D. H., Veech R. L., Song B. J. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Mol. Pharmacol. 1992; 41: 474
   PubMed Web of Science ®Google Scholar
• Lieber C. S., Lasker J. M., DeCarli L. M., Saeli J., Wojtowicz T. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system. J. Pharmacol. Exp. Ther. 1988; 247: 791
   PubMed Web of Science ®Google Scholar
• Yoo J. ‐S. H., Park H. ‐S., Ning S. M., Lee M. ‐J., Yang C. S. Effects of thiamine deficiency on hepatic cytochromes P450 and drug‐metabolizing enzyme activities. Biochem. Pharmacol. 1990; 39: 519
   PubMedGoogle Scholar
• Bellward G. D., Chang T., Rodrigues B., McNeill J. H., Maines S., Ryan D. E., Levin W., Thomas P. E. Hepatic cytochrome P450j induction in the spontaneously diabetic BB rat. Mol. Pharmacol. 1987; 33: 140
   Google Scholar
• Ma Q., Dannan G. A., Guengerich F. P., Yang C. S. Similarities and differences in the regulation of hepatic cytochrome P‐450 enzymes by diabetes and fasting in male rats. Biochem. Pharmacol. 1989; 38: 3179
   PubMed Web of Science ®Google Scholar
• Dong Z., Hong J., Ma Q., Li D., Bullock J., Gonzalez F. J., Park S. S., Gelboin H. V., Yang C. S. Mechanism of induction of cytochrome P‐450ac (P‐450j) in chemically induced and spontaneously diabetic rats. Arch. Biochem. Biophys. 1988; 263: 29
   PubMed Web of Science ®Google Scholar
• Favreau L. V., Malchoff D. M., Mole J. E., Schenkman J. B. Responses to insulin by two forms of rat hepatic microsomal cytochrome P‐450 that undergo major (RLM6) and minor (RLM5b) elevations in diabetes. J. Biol. Chem. 1987; 262: 14319
   PubMed Web of Science ®Google Scholar
• Warren B. L., Pak R., Finlayson M., Gontovnick L., Sunahara G., Bellward G. D. Differential effects of diabetes on microsomal metabolism of various substrates. Biochem. Pharmacol. 1983; 32: 327
   PubMed Web of Science ®Google Scholar
• Hussin A. H., Skett P. Lack of effect of insulin in hepatocytes isolated from streptozotocin‐diabetic male rats. Biochem. Pharmacol. 1988; 37: 1683
   PubMedGoogle Scholar
• Song B. ‐J., Matsunaga T., Hardwick J. P., Park S. S., Veech R. L., Yang C. S., Gelboin H. V., Gonzalez F. J. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. Mol. Endocrinol. 1987; 1: 542
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Morrissey J. J., LeBlanc G. A. Female‐predominant rat hepatic P450 forms j(IIEl) and 3 (IIA1) are under hormonal regulatory controls distinct from those of the sex‐specific P‐450 forms. Endocrinology 1989; 124: 2954
   PubMed Web of Science ®Google Scholar
• Yamazoe Y., Murayama N., Shimada M., Imaoka S., Funae Y., Kato R. Suppression of hepatic levels of an ethanol‐inducible P‐450DM/j by growth hormone: relationship between the increased level of P‐450DM/J and depletion of growth hormone in diabetes. Mol. Pharmacol. 1989; 36: 716
   PubMedGoogle Scholar
• Hong J. ‐Y., Ning S. M., Ma B. ‐L., Lee M. ‐J., Pan J., Yang C. S. Roles of pituitary hormones in the regulation of hepatic cytochrome P450IIE1 in rats and mice. Arch. Biochem. Biophys. 1990; 281: 132
   PubMed Web of Science ®Google Scholar
• Williams M. T., Simonent L. C. Effects of growth hormone on cytochrome P450j. Biochem. Biophys. Res. Commun. 1988; 155: 392
   PubMed Web of Science ®Google Scholar
• Waxman D. J., Morrissey J. J., LeBlanc G. A. Hypophysectomy differentially alters P‐450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P‐450 reductase. Mol. Pharmacol. 1989; 35: 519
   PubMed Web of Science ®Google Scholar
• Dicker E., McHugh T., Cederbaum A. I. Increased catalytic activity of cytochrome P‐450IIEI in pericentral hepatocytes compared to periportal hepatocytes isolated from pyrazole‐treated rats. Biochim. Biophys. Acta 1991; 1073: 316
   PubMedGoogle Scholar
• Ingelman‐Sundberg M., Johansson I., Pentilla K. E., Glaumann H., Lindros K. O. Centrilobular expression of ethanol‐inducible cytochrome P‐450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 1988; 157: 55
   PubMed Web of Science ®Google Scholar
• Shimizu M., Lasker J. M., Tsutsumi M., Lieber C. S. Immunohistochemical localization of ethanol‐inducible P450IIE1 in the rat alimentary tract. Gastroenterology 1990; 99: 1044
   PubMed Web of Science ®Google Scholar
• Ding X., Koop D. R., Crump B. L., Coon M. J. Immunochemical identification of cytochrome P450 3a (P‐450ALC) in rabbit nasal and kidney microsomes and evidence for differential induction by alcohol. Mol. Pharmacol. 1986; 30: 370
   PubMed Web of Science ®Google Scholar
• Ding X., Coon M. J. Induction of cytochrome P450 isozyme 3a (P‐450IIE1) in rabbit olfactory mucosa by ethanol and acetone. Drug Metab. Dispos. 1990; 18: 742
   PubMed Web of Science ®Google Scholar
• Schnier G. G., Laethem C. L., Koop D. R. Identification and induction of cytochromes P450, P450IIE1 and P450IA1, in rabbit bone marrow. J. Pharmacol. Exp. Ther. 1989; 251: 790
   PubMed Web of Science ®Google Scholar
• Mohla S., Ahir S., Ampy F. R. Tissue specific regulation of renal N‐nitrosodimethylamine‐de‐methylase activity by testosterone in BALB/c mice. Biochem. Pharmacol. 1988; 37: 2697
   PubMed Web of Science ®Google Scholar
• Wu D., Cederbaum A. I. Presence of functionally active cytochrome P‐450HE1 in the plasma membrane of rat hepatocytes. Hepatology 1992; 15: 515
   PubMed Web of Science ®Google Scholar
• Gough A. C., Miles J. S., Spurr N. K., Moss J. E., Gaedlgk A. M. E., Wolf C. R. Identification of the primary gene defect at the cytochrome P450 CTP2D locus. Nature 1990; 347: 773
   PubMed Web of Science ®Google Scholar
• Kagimoto M., Heim M., Kagimoto K., Zeugin T., Meyer U. A. Multiple mutations of the human cytochrome P4502D6 gene (CKP2D6) in poor metabolizers of debrisoquine: study of the functional significance of individual mutations by expression of chimeric genes. J. Biol. Chem. 1990; 265: 17209
   PubMed Web of Science ®Google Scholar
• Raucy J. L., Lasker J. M. Human P450 enzymes associated with the S‐mephenytoin 4‐hydroxylation polymorphism. Human Drug Metabolism: From Molecular Biology to Man, E. H. Jeffery. CRC Press, Boca Raton, FL 1992; 23
   Google Scholar
• Romkes‐Sparks M., Faletto M. B., Raucy J. L., Blaisdell J., Lasker J. M., Goldstein J. A. Evidence for a role for P4502C18 in the metabolism of S‐mephenytoin in humans. Biochemistry
   Google Scholar
• Skoda R. C., Gonzalez F. J., Demierre A., Meyer U. A. Two mutant alleles of human cytochrome P450dbl gene (P4502D1) associated with genetically deficient metabolism of debrisoquine and other drugs. Proc. Natl. Acad. Sci. USA 1988; 85: 5240
   PubMed Web of Science ®Google Scholar
• McBride O. W., Umeno M., Gelboin H. V., Gonzalez F. J. ATaql polymorphism in the human P450IIE1 gene on chromosome 10. (CYP2E), Nucleic Acids Res. 1987; 15: 10071
   PubMed Web of Science ®Google Scholar
• Uematsu F., Kikuchi H., Motomiya M., Abe T., Sagami I., Ohmachi T., Wakui A., Kanamaru R., Watanabe M. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res. 1991; 82: 254
   PubMedGoogle Scholar
• Watanabe J., Hayashi S., Nakachi K., Imai K., Suda Y., Sekine T., Kawajiri K. RFLPs in complete linkage disequilbrium at the CYP2E gene. Nucleic Acids Res. 1990; 18: 7194
   PubMedGoogle Scholar
• Hayashi S. ‐I., Watanabe J., Kawajiri K. Genetic polymorphism in the 5′‐flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 1991; 110: 559
   PubMed Web of Science ®Google Scholar